# Plain Language Summary: Resources To Prevent Youth Vaping Act

This bill increases the fees that tobacco companies pay to the federal government and expands which tobacco products have to pay those fees. Currently, the FDA collects user fees from manufacturers of traditional cigarettes, smokeless tobacco, and a few other established tobacco products. This bill would eventually require makers of newer products like e-cigarettes and vaping devices to pay these fees too, starting in 2024. The total fees collected would increase from about $712 million per year (for 2019-2021) to $812 million in 2022, then adjust annually based on inflation.

The money collected from these fees goes to the FDA to pay for tobacco regulation work, including inspecting products, enforcing rules, running public education campaigns about the dangers of vaping to young people, and conducting research on tobacco products. The bill's name emphasizes youth vaping prevention because one key requirement is that the FDA must report annually to Congress on how much money is being spent specifically on educating teens and young adults about the dangers of e-cigarettes and similar devices. The bill also requires tobacco companies to submit detailed sales data to the government so the FDA can fairly distribute the fees based on how much each company sells.

For consumers, this bill likely means tobacco and vaping products could become slightly more expensive, since companies typically pass fee increases along to customers. The main intended benefit is that more federal resources would go toward preventing young people from using vaping products, which has become a significant public health concern. The bill essentially treats newer vaping products the same way as traditional cigarettes when it comes to funding FDA oversight and prevention efforts.

Resources To Prevent Youth Vaping Act

Bustos, Cheri

Resources to Prevent Youth Vaping Act This bill directs the Food and Drug Administration (FDA) to collect user fees on products that it deems by regulation to be tobacco products, including electronic nicotine delivery systems, and addresses related issues. Currently, the FDA is authorized to collect user fees only on specified classes of tobacco products. The bill increases the total amount of such fees to be collected for FY2022. For each fiscal year after, the total amount of such fees shall be adjusted according to changes in a price index.&nbsp; Starting in FY2024, the FDA must assess user fees on classes of products that it has deemed by regulation to be tobacco products, unless the FDA fails to finalize a formula for assessing such fees on time. Once it is finalized, the FDA may only revise this formula by regulation. The bill also requires each tobacco manufacturer and importer to periodically submit certain information related to the tobacco products that it sells or distributes in the United States. The FDA must annually report to Congress about its use of such tobacco product fees.